Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin and vasoconstrictor synergism

O Yildiz1, J R Smith, R E Purdy

  • 1Department of Medical Pharmacology, Gulhane School of Medicine, Ankara, Turkey.

Life Sciences
|May 19, 1998
PubMed
Summary

Contractile synergism involving serotonin (5-hydroxytryptamine, 5-HT) enhances blood vessel responses. This occurs when precontraction activates "silent" 5-HT receptors, impacting conditions like hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A role for methotrexate in the management of non-infectious orbital inflammatory disease.

The British journal of ophthalmology·2001
Same author

Molecular basis for impaired muscle differentiation in myotonic dystrophy.

Molecular and cellular biology·2001
Same author

Atomic force microscopy imaging of fragments from the Martian meteorite ALH84001.

Journal of microscopy·2001
Same author

Chronic hepatitis C: implications for the primary care clinician.

JAAPA : official journal of the American Academy of Physician Assistants·2001
Same author

Effects of combining public assistance and employment on mothers and their young children.

Women & health·2001
Same author

Nodular anterior scleritis associated with ocular trauma.

Singapore medical journal·2001

Area of Science:

  • Pharmacology
  • Physiology
  • Vascular Biology

Background:

  • Contractile synergism between serotonin (5-hydroxytryptamine, 5-HT) and other vasoconstrictors is documented in peripheral and cerebrovascular vessels.
  • This interaction is significant in pathological conditions including hypertension, peripheral vascular disease, and coronary spasm.

Purpose of the Study:

  • To review existing literature on serotonin synergism with other vasoconstrictor agents.
  • To highlight a novel form of vasoconstrictor synergism involving "silent" 5-HT receptor subtypes.

Main Methods:

  • Literature review of studies investigating serotonin and vasoconstrictor interactions.
  • Focus on research describing enhanced serotonin responses mediated by previously inactive 5-HT receptor subtypes following non-5-HT agonist precontraction.

Main Results:

  • Serotonin (5-HT) exhibits synergistic effects with various vasoconstrictor substances in blood vessels.
  • A newly identified synergism involves precontraction with a non-5-HT agonist, leading to enhanced serotonin-mediated contraction.
  • This enhanced response is attributed to the activation of previously dormant or "silent" 5-HT receptor subtypes.

Conclusions:

  • Contractile synergism involving serotonin plays a crucial role in vascular physiology and pathophysiology.
  • The activation of "silent" 5-HT receptors represents a key mechanism underlying certain types of vasoconstrictor synergism.
  • Understanding these mechanisms is vital for developing therapeutic strategies for vascular diseases.
Keywords:
Non-programmatic

Related Experiment Videos